Aptus Pharma Limited (BOM:544529)
India
· Delayed Price · Currency is INR 285.30
+13.55 (4.99%)
At close: Mar 9, 2026
Aptus Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Net Income | - | 31 | 7.98 | 1.94 | - | 0.38 | Upgrade
|
| Depreciation & Amortization | - | 2.65 | 2.15 | 1.81 | - | 0.43 | Upgrade
|
| Other Amortization | - | - | - | 0 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.02 | Upgrade
|
| Other Operating Activities | - | 3.71 | 1.95 | 1.26 | - | 0.72 | Upgrade
|
| Change in Accounts Receivable | - | -22.86 | -9.56 | -5.49 | - | -3.48 | Upgrade
|
| Change in Inventory | - | -36.32 | -11.27 | -9.04 | - | -3.8 | Upgrade
|
| Change in Accounts Payable | - | -0.45 | -0.1 | 4.54 | - | 1.25 | Upgrade
|
| Change in Other Net Operating Assets | - | 3.9 | -12.89 | 3.17 | - | 3.75 | Upgrade
|
| Operating Cash Flow | - | -18.38 | -21.75 | -1.81 | - | -0.73 | Upgrade
|
| Capital Expenditures | - | -6.22 | -3.3 | -3.53 | - | -0.77 | Upgrade
|
| Other Investing Activities | - | 0.77 | 0.25 | - | - | -0.05 | Upgrade
|
| Investing Cash Flow | - | -5.45 | -3.05 | -3.53 | - | -0.82 | Upgrade
|
| Short-Term Debt Issued | - | 63.88 | 11.44 | 0.13 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 19.52 | 9.4 | - | 3.17 | Upgrade
|
| Total Debt Issued | - | 63.88 | 30.96 | 9.53 | - | 3.17 | Upgrade
|
| Long-Term Debt Repaid | - | -13.39 | - | - | - | -1.01 | Upgrade
|
| Net Debt Issued (Repaid) | - | 50.49 | 30.96 | 9.53 | - | 2.16 | Upgrade
|
| Issuance of Common Stock | - | 21 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | -4.66 | -2.39 | -1.43 | - | -0.76 | Upgrade
|
| Financing Cash Flow | - | 66.83 | 28.57 | 8.1 | - | 1.4 | Upgrade
|
| Net Cash Flow | - | 43 | 3.78 | 2.76 | - | -0.15 | Upgrade
|
| Free Cash Flow | - | -24.6 | -25.04 | -5.34 | - | -1.5 | Upgrade
|
| Free Cash Flow Margin | - | -10.02% | -14.02% | -3.84% | - | -2.94% | Upgrade
|
| Free Cash Flow Per Share | - | -5.06 | -16.69 | -7.31 | - | -2.40 | Upgrade
|
| Cash Interest Paid | - | 4.66 | 2.39 | 1.43 | - | 0.76 | Upgrade
|
| Cash Income Tax Paid | - | 11.14 | 3.39 | 1.18 | - | 0.29 | Upgrade
|
| Levered Free Cash Flow | - | -32.32 | -18.03 | -6.72 | - | -5.6 | Upgrade
|
| Unlevered Free Cash Flow | - | -30.46 | -17.03 | -6.11 | - | -5.24 | Upgrade
|
| Change in Working Capital | - | -55.74 | -33.82 | -6.82 | - | -2.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.